Publisher
Springer International Publishing
Reference26 articles.
1. ICH Q6B Specifications: Test Procedures and Acceptance Criteria For Biotechnological/Biological Products (March 1999);
www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q6B/Step4/Q6B_Guideline.pdf
2. Kozlowski, S., and Swann P., Current and Future Issues in the Manufacturing and Development of Monoclonal Antibodies; Adv. Drug Deliv Rev. (2006) 58(5–6): 707–722
3. Randhawa, Z. L., Witkowska, H. E., et. al, Incorporation of Norleucine at Methionine Positions in Recombinant Human Macrophage Colony Stimulating Factor (M-CSF, 4-153) Expressed in E. Coli: Structural Analysis; Biochemistry (1994) 33(14): 4352–4362
4. Hedayati, M. H., Norouzian, D., et.al., Identification of Methionine Oxidation in Human Recombinant Erythropoietin by Mass Spectrometry: Comparative Isoform Distribution and Biological Activity Analysis; Prep. Biochem & Biotech (2017) 47(10): 990–997
5. FDA Advisory Committee Meetings – Meeting of the Arthritis Advisory Committee: Sandoz Erlezi (Etanercept, Biosimilar Enbrel) – FDA Advisory Committee Briefing Document Prepared by the FDA (July 13, 2016);
www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM510493.pdf